Trisomy of BACH1 inhibits antioxidant genes HO‐1, leading to inhibition of HO‐1/BVR‐A pathway and facilitating AD pathology progression in DS individualsBACH1 suppress MAPT expression, leading to the observed molecular gender differences in tauopathies and AD. Here, BACH1 is linked to tauopathy.